Stay updated on Pembrolizumab in Advanced Urothelial Cancer Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab in Advanced Urothelial Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab in Advanced Urothelial Cancer Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Summary
    The record displays details for the completed KEYNOTE-052 pembrolizumab study, including its design, eligibility criteria, outcome measures, results-related publications, and study documents.
    Difference
    59%
    Check dated 2026-11-08T01:36:39.000Z thumbnail image
  2. Check
    8 days ago
    Change Detected
    Summary
    The footer revision label updates from v3.7.2 to v3.8.0; the page still displays a 403 Forbidden error instead of the study record.
    Difference
    0.2%
    Check dated 2026-10-31T20:26:45.000Z thumbnail image
  3. Check
    15 days ago
    Change Detected
    Summary
    A notice was added announcing NIH’s transition terminology, with links to updates and FAQs.
    Difference
    1%
    Check dated 2026-10-24T22:13:49.000Z thumbnail image
  4. Check
    22 days ago
    Change Detected
    Summary
    The site footer revision changed from v3.7.1 to v3.7.2, while the page continues to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-17T21:50:30.000Z thumbnail image
  5. Check
    29 days ago
    Change Detected
    Summary
    The footer’s site revision label changed from v3.7.0 to v3.7.1.
    Difference
    0.2%
    Check dated 2026-10-10T22:01:15.000Z thumbnail image
  6. Check
    50 days ago
    Change Detected
    Summary
    The page now shows a 403 Forbidden error, replacing the study details with an access-denied screen. This means users cannot view the trial information or related content on that page.
    Difference
    20%
    Check dated 2026-09-19T21:58:58.000Z thumbnail image

Stay in the know with updates to Pembrolizumab in Advanced Urothelial Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in Advanced Urothelial Cancer Clinical Trial page.